BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20204402)

  • 1. Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.
    Knechtel G; Hofmann G; Gerger A; Renner W; Langsenlehner T; Szkandera J; Wolf G; Samonigg H; Krippl P; Langsenlehner U
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1813-9. PubMed ID: 20204402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of interleukin-10 gene variation with breast cancer prognosis.
    Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
    Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
    Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
    Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
    Korobeinikova E; Myrzaliyeva D; Ugenskiene R; Raulinaityte D; Gedminaite J; Smigelskas K; Juozaityte E
    BMC Genet; 2015 Jun; 16():70. PubMed ID: 26112140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
    Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
    Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
    Hughes S; Agbaje O; Bowen RL; Holliday DL; Shaw JA; Duffy S; Jones JL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6673-80. PubMed ID: 18006768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
    Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic role of apoptosis-related gene Fas-1377 and -670 polymorphisms in breast cancer].
    Hu Y; Xu Y; Wang Y; Ouyang T; Li JF; Wang TF; Fan ZQ; Fan T; Lin BY; Geng PL; Xie YT
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):104-7. PubMed ID: 19538884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
    Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
    Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
    Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of δ-like ligand 4 contributes significantly to axillary lymph node metastasis and predicts postoperative outcome in breast cancer.
    Xiao M; Yang S; Ning X; Huang Y
    Hum Pathol; 2014 Nov; 45(11):2302-10. PubMed ID: 25260720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
    Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
    Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.